Julie Kapp

Dr. Julie Kapp

School of Medicine, University of Missouri, CE 707 Clinical Support & Education Bldg., One Hospital Drive, Columbia, MO 65212, USA

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in Annals of Epidemiology
Verified
Journal Article
Open access
JKJulie Kapp
Julie Kapp
WSWalton Sumner
Walton Sumner
Kombucha tea, a fermented beverage, has recently become popular in the United States as part of the functional food movement. This popularity is likely driven by its touted health benefits, coupled with the recent scientific movement investigating the role of the microbiome on human health. The purpose of this systematic review is to describe the literature related to empirical health benefits of kombucha as identified from human subjects research. In July 2018, we searched the term "kombucha" for all document types in the following databases across all available years: PubMed, Scopus, and Ovid. To identify federal research grants related to kombucha, we searched the National Institutes of Health Research Portfolio Online Reporting Tools. Finally, to identify ongoing human subjects research, we searched clinicaltrials.gov and clinicaltrialsregister.eu. We reviewed a total of 310 articles. We found one study reporting the results of empirical research on kombucha in human subjects. We found no results for kombucha in Research Portfolio Online Reporting Tools, clinicaltrials.gov, or clinicaltrialsregister.eu. The nonhuman subjects literature claims numerous health benefits of kombucha; it is critical that these assertions are tested in human clinical trials. Research opportunities are discussed.

14 August 2006 in Archives of internal medicine (1960)
Verified
Journal Article
Open access
PDF file
TGThomas H. Gallagher
Thomas H. Gallagher
AWAmy D. Waterman
Amy D. Waterman
JGJane M. Garbutt
Jane M. Garbutt
JKJulie Kapp
Julie Kapp
DCDavid K. Chan
David K. Chan
WLWendy Levinson
Wendy Levinson
Efforts are being launched around the world to enhance patient safety. Following the US Institute of Medicine report, To Err Is Human: Building a Safer Health System,1 England, Australia, New Zealand, and Canada also identified adverse events and errors as a major health problem.2-5 In addition, standards that promote open communication with patients following such events are rapidly emerging. In the United States, hospital accreditation standards and some state laws require that patients be told about “unanticipated outcomes,”6,7 and Senators Barack Obama and Hillary Rodham Clinton introduced legislation requiring harmful errors be disclosed to patients.8 Programs to enhance communication with patients following adverse events and errors also have been recently implemented in the United Kingdom and Australia.9,10 However, studies5,11-14 in multiple countries suggest that as little as 30% of harmful errors may be disclosed to patients. Failing to communicate effectively with patients following errors could reduce patient trust in physicians' integrity and may increase the likelihood of a lawsuit.15,16

6 January 2013 in Journal of Cancer Education
Verified
Journal Article
Closed access
PDF file
JKJulie Kapp
Julie Kapp
CPColleen Peters
Colleen Peters
DODebra Parker Oliver
Debra Parker Oliver

1 January 2007 in Journal of Nervous & Mental Disease
Verified
Journal Article
Closed access
JSJeffrey Scherrer
Jeffrey Scherrer
HXHong Xian
Hong Xian
JKJulie Kapp
Julie Kapp
BWBrian Waterman
Brian Waterman
KSKamini R. Shah
Kamini R. Shah
SESeth A. Eisen
Seth A. Eisen
The present study seeks to estimate the strength of the association between exposure to lifetime traumatic events and gambling problems while accounting for the potential contribution of psychiatric disorders, genetic factors, and family environmental influences. In 2002, structured diagnostic interviews were conducted with 1675 male twins to obtain data on exposure to traumatic events and pathological gambling. Multinomial regression tested for associations between each traumatic event and three levels of problem gambling (1-2 symptoms, at risk; 3-4 symptoms, problem gambling, and 5 or more symptoms, pathological gambling). Analyses of data from twin pairs discordant for gambling behavior controlled for genetic and family environmental factors. After adjustment for covariates, child abuse (relative risk [RR]=2.31), child neglect (RR=5.53), witnessing someone badly hurt or killed (RR=2.83), and physical attack (RR=3.39) were associated with pathological gambling. Genetic and family environmental factors significantly contributed to the association between exposure to traumatic events and one or more symptoms of problem gambling. Exposure to childhood and lifetime traumatic events are significantly associated with problem and pathological gambling. These associations are partially accounted for by psychiatric covariates and genetic and family environmental factors.

19 May 2010 in JNCI: Journal of the National Cancer Institute
Verified
Journal Article
Closed access
BYBonnie C. Yankaskas
Bonnie C. Yankaskas
SHSebastien Haneuse
Sebastien Haneuse
JKJulie Kapp
Julie Kapp
KKKarla Kerlikowske
Karla Kerlikowske
BGBerta Geller
Berta Geller
DBDiana S. M. Buist
Diana S. M. Buist
Few data have been published on mammography performance in women who are younger than 40 years. We pooled data from six mammography registries across the United States from the Breast Cancer Surveillance Consortium. We included 117 738 women who were aged 18-39 years when they had their first screening or diagnostic mammogram during 1995-2005 and followed them for 1 year to determine accuracy of mammography assessment. We measured the recall rate for screening examinations and the sensitivity, specificity, positive predictive value, and cancer detection rate for all mammograms. For screening mammograms, no cancers were detected in 637 mammograms for women aged 18-24 years. For women aged 35-39 years who had the largest number of screening mammograms (n = 73 335) in this study, the recall rate was 12.7% (95% confidence interval [CI] = 12.4% to 12.9%), sensitivity was 76.1% (95% CI = 69.2% to 82.6%), specificity was 87.5% (95% CI = 87.2% to 87.7%), positive predictive value was 1.3% (95% CI = 1.1% to 1.5%), and cancer detection rate was 1.6 cancers per 1000 mammograms (95% CI = 1.3 to 1.9 cancers per 1000 mammograms). Most (67 468 [77.7%]) of the 86 871 women screened reported no family history of breast cancer. For diagnostic mammograms, the age-adjusted rates across all age groups were: sensitivity of 85.7% (95% CI = 82.7% to 88.7%), specificity of 88.8% (95% CI = 88.4% to 89.1%), positive predictive value of 14.6% (95% CI = 13.3% to 15.8%), and cancer detection rate of 14.3 cancers per 1000 mammograms (95% CI = 13.0 to 15.7 cancers per 1000 mammograms). Mammography performance, except for specificity, improved in the presence of a breast lump. Younger women have very low breast cancer rates but after mammography experience high recall rates, high rates of additional imaging, and low cancer detection rates. We found no cancers in women younger than 25 years and poor performance for the large group of women aged 35-39 years. In a theoretical population of 10 000 women aged 35-39 years, 1266 women who are screened will receive further workup, with 16 cancers detected and 1250 women receiving a false-positive result.

1 December 2015 in Annals of Epidemiology
Verified
Journal Article
Closed access
JKJulie Kapp
Julie Kapp
BHBrian Hensel
Brian Hensel
KSKyle T. Schnoring
Kyle T. Schnoring